Short Interest in Kewaunee Scientific Corporation (NASDAQ:KEQU) Expands By 66.4%

Kewaunee Scientific Corporation (NASDAQ:KEQU) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 35,595 shares, a growth of 66.4% from the November 30th total of 21,397 shares. Based on an average daily volume of 8,858 shares, the short-interest ratio is presently 4.0 days. Currently, 1.4% of the company’s stock are sold short. Currently, 1.4% of the company’s stock are sold short. Based on an average daily volume of 8,858 shares, the short-interest ratio is presently 4.0 days.

Analyst Ratings Changes

KEQU has been the subject of a number of research analyst reports. Wall Street Zen cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Kewaunee Scientific in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Kewaunee Scientific currently has a consensus rating of “Hold”.

Kewaunee Scientific Stock Performance

Shares of NASDAQ:KEQU traded down $0.01 on Friday, reaching $38.00. 5,082 shares of the company’s stock were exchanged, compared to its average volume of 7,069. The company has a current ratio of 2.48, a quick ratio of 1.71 and a debt-to-equity ratio of 0.81. Kewaunee Scientific has a twelve month low of $30.33 and a twelve month high of $71.33. The company has a fifty day moving average of $40.25 and a 200-day moving average of $46.94. The company has a market capitalization of $109.06 million, a price-to-earnings ratio of 9.64 and a beta of 0.61.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share (EPS) for the quarter. The business had revenue of $70.10 million during the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.During the same quarter last year, the firm posted $1.01 earnings per share.

Insider Buying and Selling at Kewaunee Scientific

In other news, CFO Donald T. Gardner III sold 3,000 shares of the business’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $42.76, for a total transaction of $128,280.00. Following the transaction, the chief financial officer directly owned 11,564 shares in the company, valued at $494,476.64. The trade was a 20.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock in a transaction dated Monday, September 29th. The stock was sold at an average price of $43.42, for a total value of $80,500.68. Following the transaction, the chief executive officer owned 39,719 shares of the company’s stock, valued at $1,724,598.98. The trade was a 4.46% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 13,734 shares of company stock worth $588,087 over the last ninety days. 13.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Kewaunee Scientific

Large investors have recently modified their holdings of the stock. Susquehanna International Group LLP acquired a new stake in Kewaunee Scientific in the third quarter valued at approximately $713,000. Punch & Associates Investment Management Inc. lifted its stake in shares of Kewaunee Scientific by 61.9% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock valued at $2,989,000 after acquiring an additional 26,785 shares during the last quarter. Mink Brook Asset Management LLC lifted its stake in shares of Kewaunee Scientific by 83.4% in the 3rd quarter. Mink Brook Asset Management LLC now owns 11,571 shares of the technology company’s stock valued at $494,000 after acquiring an additional 5,261 shares during the last quarter. Minerva Advisors LLC boosted its holdings in shares of Kewaunee Scientific by 3.7% during the 3rd quarter. Minerva Advisors LLC now owns 80,274 shares of the technology company’s stock valued at $3,424,000 after acquiring an additional 2,832 shares in the last quarter. Finally, Royce & Associates LP bought a new stake in Kewaunee Scientific during the 3rd quarter worth $1,663,000. 32.69% of the stock is owned by institutional investors and hedge funds.

About Kewaunee Scientific

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.